A stem cell and gelatin sponge solution composition for knee joint injection

By injecting stem cells and gelatin sponge solution compositions for knee joints, the differentiation ability of adipose stem cells and the structural support of gelatin sponge are used to solve the problem of treatment of osteocartilage defects in knee joints and the effective cartilage and bone tissue are achieved Repair and regeneration provide more efficient and controllable therapeutic effects.

CN118542930BActive Publication Date: 2024-11-22GUANGDONG CELL BIOTECHNOLOGY CO LTD
View PDF 6 Cites 0 Cited by

Patent Information

Application Number
CN202411025281.6
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2024-07-30
Publication Date
2024-11-22
Estimated Expiration
2044-07-30

AI Technical Summary

Technical Problem

Existing knee arthritis treatments are difficult to effectively repair osteocartilage defects, resulting in pain and dysfunction. Traditional methods such as drug treatment and surgical intervention can only temporarily relieve symptoms and lack effective regenerative medicine solutions.

Method used

Provide a composition for injecting stem cells and gelatin sponge solution for knee joints, including fat stem cells, human albumin stock solution, gelatin sponge, hyaluronic acid gel, collagen, vitamin E, dextran, flavonol glycoside, plant extract, etc. Components, through the combination of multiple components, promote regeneration of cartilage tissue and reduce inflammation, provide structural support, and optimize the local environment.

Benefits of technology

By injecting knee joint lesions, multi-angle repair and regeneration of cartilage and bone tissue is achieved, which has higher efficacy and controllability compared with traditional treatment methods, significantly improving the treatment effect of osteocartilage defects.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure SMS_1
    Figure SMS_1
Patent Text Reader

Abstract

The present invention provides a stem cell and gelatin sponge solution composition for knee joint injection, comprising the following components by mass fraction: 7-12% adipose stem cells, 10-15% human albumin stock solution, 5-10% gelatin sponge, 7-10% hyaluronic acid gel, 4.2-7.0% collagen, 1.2-1.8% vitamin E, 2.5-4.0% dextran, 1-1.7% flavonol glycosides, 6.7-8.4% plant extract A, 3.4-6.3% plant extract B, 1.3-3.4% calcium glucose lactate, 1.0-2.0% cell growth factor, 0.3-0.6% allantoin, 1.6-2.5% zinc gluconate, 0.6-0.9% heparin calcium, etc., and the remainder is normal saline. The injection method is injected at the knee joint lesion, which has the characteristics of good efficacy, fast treatment and higher controllability compared with the traditional treatment method for knee arthritis.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the field of biotechnology, and in particular relates to a stem cell and gelatin sponge solution composition for knee joint injection. Background Art

[0002] Stem cell therapy has shown great potential in the treatment of knee diseases, especially knee osteoarthritis. Knee osteoarthritis is a common degenerative disease that causes wear of articular cartilage and changes in bone quality, causing pain and dysfunction. Traditional treatments such as medication, physical therapy and surgical intervention often only temporarily relieve symptoms or perform joint replacement in the late stage, while stem cell therapy provides a potential regenerative medicine solution. Stem cells, especially mesenchymal stem cells (MSCs), have attracted attention in the treatment of knee injuries and osteoarthritis due to their ability to differentiate into multiple cell types, including chondrocytes and osteoblasts. The following are the advantages of stem cell therapy for knee joints: Cartilage repair: Stem cells can differentiate into chondrocytes, promote the regeneration of cartilage tissue, and repair damaged cartilage areas. Anti-inflammatory effect: Stem cells can secrete anti-inflammatory factors, improve the inflammatory environment in the joint, and reduce further damage to cartilage caused by inflammation. Nutritional factors: Stem cells can also secrete growth factors and nutritional factors to promote the health of the joint environment and support the survival and proliferation of chondrocytes. Immunomodulation: Stem cells have immunomodulatory properties and can inhibit abnormal immune responses and reduce attacks on joints. Inhibit chondrocyte apoptosis: Factors secreted by stem cells can inhibit chondrocyte apoptosis and protect existing cartilage tissue. Autologous sources: Common sources of stem cells include bone marrow, adipose tissue and umbilical cord blood. Autologous stem cells reduce the risk of rejection and increase the safety of treatment.

[0003] Osteochondral defects are localized loss or damage of bone and the cartilage tissue that covers it, and are common in weight-bearing joints such as the knee, ankle, and hip. The defect may be caused by trauma (such as sprains, impacts), degenerative changes (such as osteoarthritis), congenital problems, or inadequate vascular supply. The goal of treating osteochondral defects is to restore the smoothness of the joint surface, relieve pain, restore joint function, and prevent or delay the onset of osteoarthritis. The treatment strategy depends on the size, location, and depth of the defect, as well as the patient's age and activity level.

[0004] Therefore, there is an urgent need for a stem cell and gelatin sponge solution composition for injection into the knee joint. Summary of the invention

[0005] The purpose of the present invention is to provide a stem cell and gelatin sponge solution composition for knee joint injection.

[0006] In order to achieve the above object, the present invention provides the following technical solutions:

[0007] A stem cell and gelatin sponge solution composition for knee joint injection comprises the following components in mass fraction: 7-12% adipose stem cells, 10-15% human albumin stock solution, 5-10% gelatin sponge, 7-10% hyaluronic acid gel, 4.2-7.0% collagen, 1.2-1.8% vitamin E, 2.5-4.0% dextran, 1-1.7% flavonol glycosides, 6.7-8.4% plant extract A, 3.4-6.3% plant extract B, 1.3-3.4% calcium gluconate lactate, 1.0-2.0% cell growth factor, 0.3-0.6% allantoin, 1.6-2.5% zinc gluconate, 0.6-0.9% heparin calcium, 0.7-1.5% emulsifier, 0.7-1.5% stabilizer, 0.2-0.6% pH regulator, 0.6-2% antioxidant, and the balance is normal saline.

[0008] Furthermore, the method for preparing adipose stem cells is: by using a cell culture plate or culture dish coated with recombinant human type IV collagen α3 and a cell culture flask coated with recombinant human type IV collagen α3, adipose stem cells with high collagen expression in fat are prepared and grown under the combined synergistic culture of recombinant human epidermal growth factor, recombinant human basic fibroblast growth factor, vitamin E and argania spinosa kernel oil.

[0009] Furthermore, the adipose stem cells can be cultured for 14 days to obtain 1×10 9 The above adipose stem cells were detected by flow cytometry, and the high expression of CD90+ was ≥95%, CD73+ was ≥95% and CD106+ was ≥95%, and the low expression of CD34+ was ≤5%, CD45+ was ≤5% and CD14+ was ≤5%.

[0010] Furthermore, the emulsifier is a mixture of poloxamer, Tween-80 and Span-80 in a mass ratio of 1:1.5-1.7:0.3-0.6.

[0011] Furthermore, the stabilizer is ascorbic acid.

[0012] Furthermore, the antioxidant is α-tocopherol.

[0013] Furthermore, the preparation method of the plant extract A is: mix Acanthopanax senticosus, Ginkgo biloba and Patchouli, crush to 80-100 mesh to obtain powder, mix the powder with deionized water in a volume ratio of 1:20-25, heat and boil at 80-90°C for 2-3h to obtain a medicinal solution, filter, and concentrate to a water content of 4-8wt% to obtain plant extract A.

[0014] Furthermore, Acanthopanax senticosus, Ginkgo biloba leaves and Patchouli are mixed in a mass ratio of 1:1.4-1.7:0.3-0.5.

[0015] Furthermore, the preparation method of the plant extract B is: mix myrrh, scutellaria and cinnamon, crush to 80-100 mesh to obtain powder, mix the powder with deionized water in a volume ratio of 1:20-25, heat and boil at 80-90°C for 2-3h to obtain a medicinal solution, filter, and concentrate to a water content of 4-8wt% to obtain plant extract B.

[0016] Furthermore, myrrh, scutellaria baicalensis and cassia bark are mixed in a mass ratio of 1:1.2-1.5:0.6-0.8.

[0017] Furthermore, the preparation method of the stem cell and gelatin sponge solution composition for knee joint injection is:

[0018] S1: adipose-derived stem cells, human albumin stock solution, hyaluronic acid gel, collagen, 1 vitamin E, dextran, flavonol glycosides, gelatin sponge, plant extract A, plant extract B, calcium gluconate lactate, cell growth factor, allantoin, zinc gluconate, heparin calcium, emulsifier, stabilizer, pH adjuster, antioxidant and physiological saline are mixed to obtain a drug mixture;

[0019] S2: adding the emulsifier, stabilizer and antioxidant to the drug mixture and stirring evenly, and adding the pH adjuster to the drug mixture to pH=7.1-7.3 during stirring to obtain an injection containing autologous adipose stem cell drugs.

[0020] Compared with the prior art, the advantages and beneficial effects of the present invention are as follows: the present invention provides a stem cell and gelatin sponge solution composition for injection into the knee joint, through the compounding of multiple components, adipose stem cells are a kind of mesenchymal stem cells, which have the ability to differentiate into multiple cell types, including chondrocytes. They can promote the regeneration of cartilage tissue, and at the same time secrete a variety of growth factors and cytokines, which are beneficial to the repair of the damaged part and the reduction of inflammation. Gelatin sponge can be used as a biological scaffold to provide structural support for the growth of new tissues, while absorbing and releasing growth factors to promote cell proliferation and tissue regeneration. The extract may contain a variety of bioactive ingredients, such as anti-inflammatory, antioxidant and cell proliferation-promoting substances. The components work together to provide a comprehensive solution for the treatment of osteochondral defects, from promoting cell proliferation, reducing inflammation, providing structural support to optimizing the local environment, and promoting the repair and regeneration of cartilage and bone tissue from multiple angles. Injection into the knee joint lesion by injection has the characteristics of good efficacy, fast treatment and higher controllability compared with the traditional treatment of knee arthritis. DETAILED DESCRIPTION

[0021] The technical solutions in the embodiments of the present invention are described clearly and completely below. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of them. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.

[0022] Example 1

[0023] The present embodiment provides a stem cell and gelatin sponge solution composition for knee joint injection, comprising the following components in mass fractions: 9% adipose stem cells, 12% human serum albumin stock solution, 8% gelatin sponge, 9% hyaluronic acid gel, 6% collagen, 1.5% vitamin E, 2.9% dextran, 1.5% flavonol glycosides, 6.7% plant extract A, 3.4% plant extract B, 1.3% calcium gluconate, 1.0% cell growth factor, 0.3% allantoin, 1.6% zinc gluconate, 0.6% heparin calcium, 0.7% emulsifier, 0.7% stabilizer, 0.2% pH regulator, 0.6% antioxidant, and the balance is normal saline.

[0024] The method for preparing adipose stem cells comprises: using a cell culture plate or a culture dish coated with recombinant human type IV collagen α3 and a cell culture bottle coated with recombinant human type IV collagen α3, and preparing and growing adipose stem cells that highly express collagen in fat under the combined synergistic culture of recombinant human epidermal growth factor, recombinant human basic fibroblast growth factor, vitamin E and argania spinosa kernel oil.

[0025] The adipose-derived stem cells can be cultured for 14 days to obtain 1×10 9 The above adipose stem cells were detected by flow cytometry, and the high expression of CD90+ was ≥95%, CD73+ was ≥95% and CD106+ was ≥95%, and the low expression of CD34+ was ≤5%, CD45+ was ≤5% and CD14+ was ≤5%.

[0026] The emulsifier is a mixture of poloxamer, Tween-80 and Span-80 in a mass ratio of 1:1.5:0.3.

[0027] The stabilizer is ascorbic acid.

[0028] The antioxidant is alpha-tocopherol.

[0029] The preparation method of the plant extract A is as follows: Acanthopanax senticosus, Ginkgo biloba leaves and Patchouli are mixed, crushed to 80 meshes to obtain powder, the powder is mixed with deionized water in a volume ratio of 1:20, heated at 80° C. for h to obtain a medicinal solution, filtered, and concentrated to a water content of 4wt%, to obtain the plant extract A.

[0030] Acanthopanax senticosus, Ginkgo biloba leaves and Patchouli are mixed in a mass ratio of 1:1.4:0.3.

[0031] The preparation method of the plant extract B is as follows: myrrh, scutellaria baicalensis and cassia bark are mixed, crushed to 80 meshes to obtain powder, the powder is mixed with deionized water at a volume ratio of 1:20, heated at 80° C. for 2 hours to obtain a medicinal solution, filtered, and concentrated to a water content of 4-8wt% to obtain the plant extract B.

[0032] Myrrh, Scutellaria baicalensis and cinnamon bark are mixed in a mass ratio of 1:1.2:0.6.

[0033] The preparation method of the stem cell and gelatin sponge solution composition for knee joint injection is as follows:

[0034] S1: adipose-derived stem cells, human albumin stock solution, hyaluronic acid gel, collagen, 1 vitamin E, dextran, flavonol glycosides, gelatin sponge, plant extract A, plant extract B, calcium gluconate lactate, cell growth factor, allantoin, zinc gluconate, heparin calcium, emulsifier, stabilizer, pH adjuster, antioxidant and physiological saline are mixed to obtain a drug mixture;

[0035] S2: adding the emulsifier, stabilizer and antioxidant to the drug mixture and stirring evenly, and adding the pH adjuster to the drug mixture to pH=7.1 during stirring to obtain an injection containing autologous adipose stem cell drugs.

[0036] Example 2

[0037] The present embodiment provides a stem cell and gelatin sponge solution composition for knee joint injection, comprising the following components in mass fractions: 12% adipose stem cells, 15% human albumin stock solution, 10% gelatin sponge, 10% hyaluronic acid gel, 7.0% collagen, 1.8% vitamin E, 4.0% dextran, 1.7% flavonol glycosides, 8.4% plant extract A, 6.3% plant extract B, 3.4% calcium gluconate, 2.0% cell growth factor, 0.6% allantoin, 2.5% zinc gluconate, 0.9% heparin calcium, 1.5% emulsifier, 1.5% stabilizer, 0.6% pH regulator, 2% antioxidant, and the balance is normal saline.

[0038] The method for preparing adipose stem cells comprises: using a cell culture plate or a culture dish coated with recombinant human type IV collagen α3 and a cell culture bottle coated with recombinant human type IV collagen α3, and preparing and growing adipose stem cells that highly express collagen in fat under the combined synergistic culture of recombinant human epidermal growth factor, recombinant human basic fibroblast growth factor, vitamin E and argania spinosa kernel oil.

[0039] The adipose-derived stem cells can be cultured for 14 days to obtain 1×10 9 The above adipose stem cells were detected by flow cytometry, and the high expression of CD90+ was ≥95%, CD73+ was ≥95% and CD106+ was ≥95%, and the low expression of CD34+ was ≤5%, CD45+ was ≤5% and CD14+ was ≤5%.

[0040] The emulsifier is a mixture of poloxamer, Tween-80 and Span-80 in a mass ratio of 1:1.7:0.6.

[0041] The stabilizer is ascorbic acid.

[0042] The antioxidant is alpha-tocopherol.

[0043] The preparation method of the plant extract A is as follows: Acanthopanax senticosus, Ginkgo biloba leaves and Patchouli are mixed, crushed to 100 meshes to obtain powder, the powder is mixed with deionized water at a volume ratio of 1:25, heated at 90° C. for 3 hours to obtain a medicinal solution, filtered, and concentrated to a water content of 8wt%, to obtain the plant extract A.

[0044] Acanthopanax senticosus, Ginkgo biloba leaves and Patchouli are mixed in a mass ratio of 1:1.7:0.5.

[0045] The preparation method of the plant extract B is as follows: myrrh, scutellaria baicalensis and cassia bark are mixed, crushed to 100 meshes to obtain powder, the powder is mixed with deionized water in a volume ratio of 1:25, heated at 90° C. for 3 hours to obtain a medicinal solution, filtered, and concentrated to a water content of 8wt% to obtain the plant extract B.

[0046] Myrrh, Scutellaria baicalensis and cinnamon bark are mixed in a mass ratio of 1:1.5:0.8.

[0047] The preparation method of the stem cell and gelatin sponge solution composition for knee joint injection is as follows:

[0048] S1: adipose-derived stem cells, human albumin stock solution, hyaluronic acid gel, collagen, 1 vitamin E, dextran, flavonol glycosides, gelatin sponge, plant extract A, plant extract B, calcium gluconate lactate, cell growth factor, allantoin, zinc gluconate, heparin calcium, emulsifier, stabilizer, pH adjuster, antioxidant and physiological saline are mixed to obtain a drug mixture;

[0049] S2: adding the emulsifier, stabilizer and antioxidant to the drug mixture and stirring evenly, and adding the pH adjuster to the drug mixture to pH=7.3 during the stirring process to obtain an injection containing autologous adipose stem cell drugs.

[0050] Comparative Example 1

[0051] The difference between this comparative example and Example 1 is that the plant extracts are different.

[0052] A stem cell and gelatin sponge solution composition for knee joint injection comprises the following components in mass fraction: 9% adipose stem cells, 12% human albumin stock solution, 8% gelatin sponge, 9% hyaluronic acid gel, 6% collagen, 1.5% vitamin E, 2.9% dextran, 1.5% flavonol glycosides, 6.7% plant extract A, 3.4% plant extract B, 1.3% calcium gluconate lactate, 1.0% cell growth factor, 0.3% allantoin, 1.6% zinc gluconate, 0.6% heparin calcium, 0.7% emulsifier, 0.7% stabilizer, 0.2% pH regulator, 0.6% antioxidant, and the balance is normal saline.

[0053] The method for preparing adipose stem cells comprises: using a cell culture plate or a culture dish coated with recombinant human type IV collagen α3 and a cell culture bottle coated with recombinant human type IV collagen α3, and preparing and growing adipose stem cells that highly express collagen in fat under the combined synergistic culture of recombinant human epidermal growth factor, recombinant human basic fibroblast growth factor, vitamin E and argania spinosa kernel oil.

[0054] The adipose-derived stem cells can be cultured for 14 days to obtain 1×10 9 The above adipose stem cells were detected by flow cytometry, and the high expression of CD90+ was ≥95%, CD73+ was ≥95% and CD106+ was ≥95%, and the low expression of CD34+ was ≤5%, CD45+ was ≤5% and CD14+ was ≤5%.

[0055] The emulsifier is a mixture of poloxamer, Tween-80 and Span-80 in a mass ratio of 1:1.5:0.3.

[0056] The stabilizer is ascorbic acid.

[0057] The antioxidant is alpha-tocopherol.

[0058] The preparation method of the plant extract A is as follows: Acanthopanax senticosus, Ginkgo biloba leaves and Patchouli are mixed, crushed to 80 meshes to obtain powder, the powder is mixed with deionized water in a volume ratio of 1:20, heated at 80° C. for h to obtain a medicinal solution, filtered, and concentrated to a water content of 4wt%, to obtain the plant extract A.

[0059] The mass ratio of Acanthopanax senticosus, Ginkgo biloba leaves and Patchouli is 1:1:1.

[0060] The preparation method of the plant extract B is as follows: myrrh, scutellaria baicalensis and cassia bark are mixed, crushed to 80 meshes to obtain powder, the powder is mixed with deionized water at a volume ratio of 1:20, heated at 80° C. for 2 hours to obtain a medicinal solution, filtered, and concentrated to a water content of 4-8wt% to obtain the plant extract B.

[0061] Myrrh, Scutellaria baicalensis and cinnamon bark are mixed in a mass ratio of 1:1:1.

[0062] The preparation method of the stem cell and gelatin sponge solution composition for knee joint injection is as follows:

[0063] S1: adipose-derived stem cells, human albumin stock solution, hyaluronic acid gel, collagen, 1 vitamin E, dextran, flavonol glycosides, gelatin sponge, plant extract A, plant extract B, calcium gluconate lactate, cell growth factor, allantoin, zinc gluconate, heparin calcium, emulsifier, stabilizer, pH adjuster, antioxidant and physiological saline are mixed to obtain a drug mixture;

[0064] S2: adding the emulsifier, stabilizer and antioxidant to the drug mixture and stirring evenly, and adding the pH adjuster to the drug mixture to pH=7.1 during stirring to obtain an injection containing autologous adipose stem cell drugs.

[0065] Comparative Example 2

[0066] The difference between this comparative example and Example 1 is that the component contents are different.

[0067] A stem cell and gelatin sponge solution composition for knee joint injection comprises the following components in mass fraction: 15% adipose stem cells, 5% human albumin stock solution, 5% gelatin sponge, 9% hyaluronic acid gel, 6% collagen, 1.5% vitamin E, 2.9% dextran, 1.5% flavonol glycosides, 3.7% plant extract A, 10.4% plant extract B, 1.3% calcium glucose lactate, 1.0% cell growth factor, 0.3% allantoin, 1.6% zinc gluconate, 0.6% heparin calcium, 0.7% emulsifier, 0.7% stabilizer, 0.2% pH regulator, 0.6% antioxidant, and the balance is normal saline.

[0068] The method for preparing adipose stem cells comprises: using a cell culture plate or a culture dish coated with recombinant human type IV collagen α3 and a cell culture bottle coated with recombinant human type IV collagen α3, and preparing and growing adipose stem cells that highly express collagen in fat under the combined synergistic culture of recombinant human epidermal growth factor, recombinant human basic fibroblast growth factor, vitamin E and argania spinosa kernel oil.

[0069] The adipose-derived stem cells can be cultured for 14 days to obtain 1×10 9The above adipose stem cells were detected by flow cytometry, and the high expression of CD90+ was ≥95%, CD73+ was ≥95% and CD106+ was ≥95%, and the low expression of CD34+ was ≤5%, CD45+ was ≤5% and CD14+ was ≤5%.

[0070] The emulsifier is a mixture of poloxamer, Tween-80 and Span-80 in a mass ratio of 1:1.5:0.3.

[0071] The stabilizer is ascorbic acid.

[0072] The antioxidant is alpha-tocopherol.

[0073] The preparation method of the plant extract A is as follows: Acanthopanax senticosus, Ginkgo biloba leaves and Patchouli are mixed, crushed to 80 meshes to obtain powder, the powder is mixed with deionized water in a volume ratio of 1:20, heated at 80° C. for h to obtain a medicinal solution, filtered, and concentrated to a water content of 4wt%, to obtain the plant extract A.

[0074] Acanthopanax senticosus, Ginkgo biloba leaves and Patchouli are mixed in a mass ratio of 1:1.4:0.3.

[0075] The preparation method of the plant extract B is as follows: myrrh, scutellaria baicalensis and cassia bark are mixed, crushed to 80 meshes to obtain powder, the powder is mixed with deionized water at a volume ratio of 1:20, heated at 80° C. for 2 hours to obtain a medicinal solution, filtered, and concentrated to a water content of 4-8wt% to obtain the plant extract B.

[0076] Myrrh, Scutellaria baicalensis and cinnamon bark are mixed in a mass ratio of 1:1.2:0.6.

[0077] The preparation method of the stem cell and gelatin sponge solution composition for knee joint injection is as follows:

[0078] S1: adipose-derived stem cells, human albumin stock solution, hyaluronic acid gel, collagen, 1 vitamin E, dextran, flavonol glycosides, gelatin sponge, plant extract A, plant extract B, calcium gluconate lactate, cell growth factor, allantoin, zinc gluconate, heparin calcium, emulsifier, stabilizer, pH adjuster, antioxidant and physiological saline are mixed to obtain a drug mixture;

[0079] S2: adding the emulsifier, stabilizer and antioxidant to the drug mixture and stirring evenly, and adding the pH adjuster to the drug mixture to pH=7.1 during stirring to obtain an injection containing autologous adipose stem cell drugs.

[0080] Performance Testing

[0081] 1. Case selection: 600 patients who needed osteochondral defect treatment in a provincial tertiary hospital were selected for clinical observation, 120 cases in each group; the medical records of the two groups of patients were basically the same, with no significant difference, and they were comparable.

[0082] 2. Treatment method: The treatment group was injected with the composition of the present invention into the joint cavity, and the control group was injected with the commercially available EntoxinTM stem cell factor injection into the joint cavity.

[0083] 3. Treatment results: According to the different conditions and physical conditions of different patients, the follow-up period is 6-24 months.

[0084] Table 1 Performance test results (unit: example)

[0085]

[0086] It can be seen from the above performance test results that the therapeutic effect of Example 1-2 is good.

[0087] However, the comparative example does not adopt the necessary technical solution, resulting in its performance being significantly worse than that of the embodiment in the corresponding performance test. The above experimental results further prove the importance of the technical solution defined in the present invention to its technical effect.

[0088] The above is a preferred embodiment of the present invention. It should be pointed out that for ordinary technicians in this technical field, several improvements and modifications can be made without departing from the principles of the present invention. These improvements and modifications should also be regarded as the scope of protection of the present invention.

Claims

1. Use of a stem cell and gelatin sponge composition for knee joint injection in the preparation of a drug for treating cartilage defects, characterized in that: The composition comprises the following components by mass fraction: 9% adipose stem cells, 12% human albumin stock solution, 8% gelatin sponge, 9% hyaluronic acid gel, 6% collagen, 1.5% vitamin E, 2.9% dextran, 1.5% flavonol glycosides, 6.7% plant extract A, 3.4% plant extract B, 1.3% calcium gluconate lactate, 1.0% cell growth factor, 0.3% allantoin, 1.6% zinc gluconate, 0.6% heparin calcium, 0.7% emulsifier, 0.7% stabilizer, 0.2% pH regulator, 0.6% antioxidant, and the balance is normal saline; The method for preparing adipose stem cells comprises: using a cell culture plate, a cell culture dish or a cell culture bottle coated with recombinant human type IV collagen α3, and using adipose stem cells with high collagen expression in fat to prepare and grow under the combined synergistic culture of recombinant human epidermal growth factor, recombinant human basic fibroblast growth factor, vitamin E and argania spinosa kernel oil; The adipose-derived stem cells can be cultured for 14 days to obtain 1×10 9 The above adipose stem cells, detected by flow cytometry, have high expression of CD90+ ≥95%, CD73+ ≥95% and CD106+ ≥95%, low expression of CD34+ ≤5%, CD45+ ≤5% and CD14+ ≤5%; The emulsifier is a mixture of poloxamer, Tween-80 and Span-80 in a mass ratio of 1:1.5:0.3; The antioxidant is α-tocopherol; the stabilizer is ascorbic acid; The preparation method of the plant extract A is as follows: Acanthopanax senticosus, Ginkgo biloba leaves and Patchouli are mixed in a mass ratio of 1:1.4:0.3, crushed to 80 meshes to obtain powder, the powder is mixed with deionized water in a volume ratio of 1:20, heated at 80°C for 2h to obtain a liquid, filtered, and concentrated to a water content of 4-8wt% to obtain the plant extract A; The preparation method of the plant extract B is as follows: myrrh, scutellaria baicalensis and cassia bark are mixed in a mass ratio of 1:1.2:0.6, crushed to 80-100 mesh to obtain powder, the powder is mixed with deionized water in a volume ratio of 1:20-25, heated at 80-90°C for 2-3h to obtain a medicinal solution, filtered, and concentrated to a water content of 4-8wt% to obtain the plant extract B.

2. The use according to claim 1, characterized in that: The preparation method of the stem cell and gelatin sponge composition for knee joint injection is as follows: S1: adipose-derived stem cells, human albumin stock solution, hyaluronic acid gel, collagen, vitamin E, dextran, flavonol glycosides, gelatin sponge, plant extract A, plant extract B, calcium gluconate lactate, cell growth factor, allantoin, zinc gluconate, heparin calcium, emulsifier, stabilizer, pH regulator, antioxidant and physiological saline are mixed to obtain a drug mixture; S2: adding the emulsifier, stabilizer and antioxidant to the drug mixture and stirring evenly, and adding the pH adjuster to the drug mixture to pH = 7.1-7.3 during stirring to obtain a composition containing autologous adipose stem cells.

Citation Information

Patent Citations

  • Methods and compositions for repair of cartilage using an in vivo bioreactor

    AU2011253785A1

  • Composition for treating osteoarthritis

    CN104706675A

  • Applications of umbilical cord blood mesenchymal stem cell medicine in promoting regeneration of knee joint cartilage

    CN108578617A

  • Stem cell medicine for treating gonarthritis and using autologous adipose-derived stem cells for preparation

    CN108904783A

  • Culture method of adipose-derived stem cells and application of adipose-derived stem cells in arthritis

    CN111607560A